Iguana Healthcare Management Upped Stake in Adma Biologics (ADMA) as Market Valuation Declined; Tenet Healthcare (THC) Shareholder Saba Capital Management LP Has Lifted Its Position

January 13, 2018 - By Marie Mckinney

Stuart Weisbrod increased its stake in Adma Biologics Inc (ADMA) by 276.67% based on its latest 2017Q3 regulatory filing with the SEC. Iguana Healthcare Management Llc bought 415,000 shares as the company’s stock declined 24.29% while stock markets rallied. The hedge fund run by Stuart Weisbrod held 565,000 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $1.74 million, up from 150,000 at the end of the previous reported quarter. Iguana Healthcare Management Llc who had been investing in Adma Biologics Inc for a number of months, seems to be bullish on the $161.78 million market cap company. The stock decreased 3.25% or $0.12 during the last trading session, reaching $3.57. About 199,337 shares traded or 16.59% up from the average. ADMA Biologics, Inc. (NASDAQ:ADMA) has declined 37.56% since January 13, 2017 and is downtrending. It has underperformed by 54.26% the S&P500.

Boaz Weinstein increased its stake in Tenet Healthcare Corp (THC) by 26.62% based on its latest 2017Q3 regulatory filing with the SEC. Saba Capital Management Lp bought 215,714 shares as the company’s stock declined 9.34% while stock markets rallied. The hedge fund run by Boaz Weinstein held 1.03M shares of the hospital and nursing management company at the end of 2017Q3, valued at $16.86 million, up from 810,262 at the end of the previous reported quarter. Saba Capital Management Lp who had been investing in Tenet Healthcare Corp for a number of months, seems to be bullish on the $1.64B market cap company. The stock increased 5.31% or $0.82 during the last trading session, reaching $16.25. About 5.47M shares traded or 64.64% up from the average. Tenet Healthcare Corporation (NYSE:THC) has declined 36.81% since January 13, 2017 and is downtrending. It has underperformed by 53.51% the S&P500.

Saba Capital Management Lp, which manages about $7.93B and $986.86M US Long portfolio, decreased its stake in Putman High Income Sec Fund (PCF) by 294,728 shares to 30,173 shares, valued at $269,000 in 2017Q3, according to the filing. It also reduced its holding in Alpine Global Dynamic Divd F (AGD) by 140,774 shares in the quarter, leaving it with 612,408 shares, and cut its stake in Legg Mason Bw Glb Inc Opp Fd (BWG).

Among 22 analysts covering Tenet Healthcare Corporation (NYSE:THC), 9 have Buy rating, 4 Sell and 9 Hold. Therefore 41% are positive. Tenet Healthcare Corporation had 71 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Ladenburg Thalmann to “Underperform” on Monday, June 13. Credit Suisse maintained Tenet Healthcare Corporation (NYSE:THC) rating on Thursday, March 24. Credit Suisse has “Neutral” rating and $31 target. The stock of Tenet Healthcare Corporation (NYSE:THC) has “Neutral” rating given on Monday, March 27 by Mizuho. Jefferies maintained the stock with “Buy” rating in Tuesday, August 8 report. Deutsche Bank maintained Tenet Healthcare Corporation (NYSE:THC) on Wednesday, April 5 with “Buy” rating. As per Thursday, August 10, the company rating was maintained by Deutsche Bank. On Monday, October 30 the stock rating was maintained by Jefferies with “Buy”. The stock of Tenet Healthcare Corporation (NYSE:THC) earned “Hold” rating by Goldman Sachs on Wednesday, January 3. J.P. Morgan downgraded Tenet Healthcare Corporation (NYSE:THC) rating on Thursday, December 14. J.P. Morgan has “Sell” rating and $15.0 target. Mizuho maintained it with “Neutral” rating and $22 target in Wednesday, October 5 report.

Investors sentiment increased to 1.33 in Q3 2017. Its up 0.08, from 1.25 in 2017Q2. It improved, as 33 investors sold THC shares while 57 reduced holdings. 41 funds opened positions while 79 raised stakes. 122.38 million shares or 7.67% more from 113.66 million shares in 2017Q2 were reported. Edge Wealth Management Ltd Llc reported 60 shares stake. Moreover, Sg Americas Limited Liability Com has 0.04% invested in Tenet Healthcare Corporation (NYSE:THC). State Street Corp holds 2.94 million shares. Ameritas Invest Partners reported 31,287 shares stake. Nomura Hldg accumulated 0.01% or 240,000 shares. State Bank Of America Corporation De reported 0% in Tenet Healthcare Corporation (NYSE:THC). Fmr Llc invested 0.01% in Tenet Healthcare Corporation (NYSE:THC). Guggenheim Limited Liability Company owns 95,405 shares. Highland Mngmt Limited Partnership has invested 0.23% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Pentwater Capital Management Limited Partnership has 0% invested in Tenet Healthcare Corporation (NYSE:THC) for 10,000 shares. Thrivent For Lutherans owns 0% invested in Tenet Healthcare Corporation (NYSE:THC) for 17,420 shares. Moreover, Carroll Fincl Inc has 0% invested in Tenet Healthcare Corporation (NYSE:THC) for 101 shares. Great West Life Assurance Can holds 0% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 76,023 shares. Balyasny Asset Limited Liability Corporation owns 1.45 million shares. California Pub Employees Retirement Systems has 0.02% invested in Tenet Healthcare Corporation (NYSE:THC).

Among 2 analysts covering ADMA Biologics (NASDAQ:ADMA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ADMA Biologics had 8 analyst reports since September 9, 2015 according to SRatingsIntel. Raymond James initiated ADMA Biologics, Inc. (NASDAQ:ADMA) on Wednesday, September 9 with “Strong Buy” rating. The company was maintained on Thursday, September 17 by Maxim Group. The stock of ADMA Biologics, Inc. (NASDAQ:ADMA) earned “Buy” rating by Maxim Group on Wednesday, June 28. Raymond James downgraded ADMA Biologics, Inc. (NASDAQ:ADMA) on Monday, August 1 to “Market Perform” rating. The firm earned “Buy” rating on Wednesday, June 7 by Maxim Group. Maxim Group downgraded the shares of ADMA in report on Monday, August 1 to “Hold” rating. As per Monday, January 23, the company rating was upgraded by Maxim Group. The stock of ADMA Biologics, Inc. (NASDAQ:ADMA) earned “Outperform” rating by Raymond James on Tuesday, November 14.

Iguana Healthcare Management Llc, which manages about $139.00 million and $183.53 million US Long portfolio, decreased its stake in Anaptysbio Inc by 20,000 shares to 50,000 shares, valued at $1.75 million in 2017Q3, according to the filing. It also reduced its holding in Avexis Inc by 12,500 shares in the quarter, leaving it with 17,500 shares, and cut its stake in Zogenix Inc.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.58, from 0.56 in 2017Q2. It is positive, as 4 investors sold ADMA shares while 3 reduced holdings. 3 funds opened positions while 5 raised stakes. 7.02 million shares or 6.17% less from 7.48 million shares in 2017Q2 were reported. Tower Research Cap Limited Liability (Trc) stated it has 0% in ADMA Biologics, Inc. (NASDAQ:ADMA). Geode Capital Mgmt Limited Co holds 0% or 21,526 shares. Millennium Lc has 19,078 shares for 0% of their portfolio. Aisling Lc accumulated 3.61 million shares. Iguana Management Limited Liability holds 565,000 shares or 0.97% of its portfolio. Morgan Stanley owns 4,863 shares for 0% of their portfolio. Perceptive Ltd Liability Company holds 0.08% of its portfolio in ADMA Biologics, Inc. (NASDAQ:ADMA) for 721,102 shares. Royal Financial Bank Of Canada holds 0% of its portfolio in ADMA Biologics, Inc. (NASDAQ:ADMA) for 2 shares. Blackrock Inc invested 0% in ADMA Biologics, Inc. (NASDAQ:ADMA). Northern Tru Corporation has invested 0% in ADMA Biologics, Inc. (NASDAQ:ADMA). Financial Bank Of America De accumulated 4 shares. Consonance Mngmt Limited Partnership accumulated 1.27 million shares or 0.43% of the stock. Prelude Management Ltd Liability Co holds 39,000 shares or 0.01% of its portfolio. Vanguard Grp Inc accumulated 311,514 shares. Bank & Trust Of New York Mellon reported 0% in ADMA Biologics, Inc. (NASDAQ:ADMA).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>